Urology · Lancaster, PA
NPI
1851684484
Since 2011
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2106 Harrisburg Pike Ste 200
Lancaster, PA, 17601
Phone (717) 393-1771
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
23,166 services
Medicare patients, 2024
802
Average age 75
Drug cost, 2024
$237K
2,264 prescriptions
Company payments, 2025
$405
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark S Hockenberry was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,825 times for 18 patients. In total Mark S Hockenberry billed 23,166 services in 89 codes, and Medicare paid $186K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,825 | 18 | $0.10 | $176 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 535 | 372 | $11.50 | $6,150 |
| 99214 Office E&M - Established | Office | 526 | 362 | $81.47 | $43K |
| 99213 Office E&M - Established | Office | 218 | 177 | $58.04 | $13K |
| 81003 Clinical Chemistry | Office | 200 | 161 | $2.18 | $436 |
| 81001 Clinical Chemistry | Office | 168 | 145 | $3.11 | $522 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 114 | 113 | $70.03 | $7,983 |
| 51798 Ultrasound - Nonspecific | Office | 89 | 84 | $7.09 | $631 |
| 52000 Cystourethroscopy | Facility | 87 | 76 | $56.52 | $4,918 |
| 99231 Hospital E&M - Subsequent | Facility | 74 | 61 | $37.29 | $2,759 |
| 99221 Hospital E&M - Initial | Facility | 60 | 58 | $61.09 | $3,665 |
| 51702 Other Organ Systems | Office | 37 | 18 | $43.63 | $1,614 |
| 76872 Ultrasound - Nonspecific | Office | 32 | 32 | $91.80 | $2,937 |
| 99204 Office E&M - New | Office | 32 | 32 | $97.52 | $3,121 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $98.40 | $2,755 |
By year: 2022 $190K for 23,650 services; 2023 $198K for 23,400 services; 2024 $186K for 23,166 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 200 | 161 | $2.18 | $436 |
| 81001 Clinical Chemistry | 168 | 145 | $3.11 | $522 |
| 36415 Venipuncture Blood Collection | 24 | 22 | $8.65 | $208 |
| 84153 Clinical Chemistry | 19 | 18 | $18.02 | $342 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Hockenberry prescribed most often to Medicare patients was Finasteride, with 445 prescriptions and refills. In total Mark S Hockenberry wrote 2,264 Medicare prescriptions that cost $237K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 445 | 1,264 | 130 | $6,130 |
| Tamsulosin Hcl Generic | 428 | 1,169 | 143 | $6,962 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 202 | 576 | 66 | $4,649 |
| Testosterone Generic | 160 | 198 | 41 | $19K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 113 | 249 | 36 | $2,831 |
| Oxybutynin Chloride Generic | 99 | 109 | 90 | $324 |
| Myrbetriq Mirabegron | 94 | 152 | 28 | $66K |
| Oxycodone Hcl Generic | 88 | 88 | 85 | $122 |
| Dutasteride Generic | 72 | 192 | 20 | $1,299 |
| Levofloxacin Generic | 66 | 66 | 55 | $60.02 |
| Anastrozole Generic | 55 | 149 | 23 | $228 |
| Gemtesa Vibegron | 54 | 80 | Under 11 | $37K |
| Testosterone Cypionate Generic | 49 | 92 | 20 | $2,696 |
| Methenamine Hippurate Generic | 37 | 99 | 11 | $3,355 |
| Jatenzo Testosterone Undecanoate | 33 | 33 | Under 11 | $34K |
Brand drugs: - claims; generic drugs: 2,033 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Hockenberry $405 ($405 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $88.24.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $88.24 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $53.82 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $35.06 |
| Verity Pharmaceuticals Inc. | 1 | $31.24 |
| Novo Nordisk Inc NVO | 1 | $30.52 |
| Olympus America Inc. | 1 | $29.41 |
| Avyxa Pharma, LLC | 1 | $28.46 |
| Antares Pharma, Inc. | 1 | $20.57 |
| Teleflex LLC TFX | 1 | $18.67 |
| Ethicon US, LLC JNJ | 1 | $18.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.